Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study
A. J. C. Eijlers(Amsterdam Neuroscience), Jeroen J.G. Geurts(Amsterdam Neuroscience), Iris Dekker(Amsterdam Neuroscience), Hanneke E. Hulst(Amsterdam UMC Location Vrije Universiteit Amsterdam), Kim Meijer(Amsterdam Neuroscience), Frederik Barkhof(Netherlands Institute for Neuroscience), Martijn D. Steenwijk(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Menno M. Schoonheim(Amsterdam Neuroscience), Quinten van Geest(Amsterdam Neuroscience)
Cited by 212
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k